✦ LIBER ✦

Failure to identify specific sequence variations in genotype 1b HCV NS58 associated with response to interferon/ribavirin therapy

✍ Scribed by Lai, Vicky Ch; Wright, Teresa L.; Gish, Robert G.; Mizokami, Massashi; Zhong, Weidong; Yao, Nanhua; Yn Lau, Johnson; Hong, Zhi

Book ID: 124138902
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 185 KB
Volume: 120
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(08)81825-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Assessment of Hepatitis C Virus Protein

Assessment of Hepatitis C Virus Protein Sequences with Regard to Interferon/Ribavirin Combination Therapy Response in Patients with HCV Genotype 1b

✍ Sanja Glisic; Nevena Veljkovic; Snezana Jovanovic Cupic; Nada Vasiljevic; Jelena 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 344 KB

An early viral response to standard inte

An early viral response to standard interferon-alpha identifies resistance to combination therapy with peginterferon and ribavirin in patients infected by HCV genotype 1

✍ Hidenori Toyoda; Takashi Kumada; Seiki Kiriyama; Makoto Tanikawa; Yasuhiro Hisan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 1 views

## Abstract As combination therapy with peginterferon (PEG‐IFN) and ribavirin has a high morbidity, identifying individuals with hepatitis C virus (HCV) who will not respond to the treatment would be beneficial. The early responses of serum HCV RNA levels to standard interferon (IFN) and PEG‐IFN we

258 ASSOCIATION OF SERUM INTERFERON-GAMM

258 ASSOCIATION OF SERUM INTERFERON-GAMMA INDUCIBLE PROTEIN 10 (IP-10) LEVELS WITH VIROLOGICAL RESPONSE TO PEGYLATED INTERFERON ALFA-2B PLUS RIBAVIRIN THERAPY FOR HCV GENOTYPE 1 INFECTION

✍ M. Fukuda; H. Yatsuhashi; I. Takahara; T. Murata; S. Hashimoto; A. Nishikawa; S. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Mutation frequency of NS5A in patients v

Mutation frequency of NS5A in patients vertically infected with HCV genotype 1 predicts sustained virological response to peginterferon alfa-2b and ribavirin combination therapy

✍ A. C. W. Jenke; S. Moser; V. Orth; M. Zilbauer; P. Gerner; S. Wirth 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

Mutations in the core and NS5A region of

Mutations in the core and NS5A region of hepatitis C virus genotype 1b and correlation with response to pegylated-interferon-alpha 2b and ribavirin combination therapy

✍ K. Hayashi; Y. Katano; M. Ishigami; A. Itoh; Y. Hirooka; I. Nakano; F. Urano; K. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

A mutation in the interferon sensitivity

A mutation in the interferon sensitivity-determining region is associated with responsiveness to interferon-ribavirin combination therapy in chronic hepatitis patients infected with a Japan-specific subtype of hepatitis C virus genotype 1b

✍ Mutsumi Murayama; Yoshiaki Katano; Isao Nakano; Masatoshi Ishigami; Kazuhiko Hay 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB 👁 2 views

## Abstract The interferon sensitivity‐determining region (ISDR) is useful as a predictive marker of the response to interferon (IFN) therapy for chronic hepatitis patients with a Japan‐specific subtype (J‐type) of hepatitis C virus (HCV) genotype 1b. This marker is not useful for predicting respon